Pre-operative chemoradiotherapy and adjuvant chemotherapy with 5-FU in comparison with a pre-operative chemoradiotherapy and adjuvant chemotherapy with 5-Fu plus Oxaliplatin in localized advanced rectal cancer in UICC-stage 2 and 3 (CAO/ARO/AIO-04)

被引：0
|
作者：
Sauer, R. [1 ]
机构：
[1] Univ Strahlenklin, Erlangen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 25 条
  • [21] Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
    Roedel, Claus
    Graeven, Ullrich
    Fietkau, Rainer
    Hohenberger, Werner
    Hothorn, Torsten
    Arnold, Dirk
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Wolff, Hendrik A.
    Lang-Welzenbach, Marga
    Raab, Hans-Rudolf
    Wittekind, Christian
    Stroebel, Philipp
    Staib, Ludger
    Wilhelm, Martin
    Grabenbauer, Gerhard G.
    Manns, Hans Hoff
    Lindemann, Fritz
    Schlenska-Lange, Anke
    Folprecht, Gunnar
    Sauer, Rolf
    Liersch, Torsten
    Sauer, R.
    Hohenberger, W.
    Fietkau, R.
    Lahmer, G.
    Golcher, H.
    Klautke, G.
    Hartmann, A.
    Rau, T.
    Keilholz, L.
    Henneking, K.
    Muehldorfer, S.
    Klein, S.
    Stolte, M.
    Staar, S.
    Lehnert, T.
    Hertenstein, B.
    Freys, S. M.
    Pflueger, K.-H.
    Sendt, W.
    Teyssen, S.
    Latz, D.
    Leibl, B. J.
    Matek, W.
    Grabenbauer, G. G.
    Alfrink, M.
    Kreczy, A.
    Strobel, G. F.
    Düwel, H.-J.
    LANCET ONCOLOGY, 2015, 16 (08): : 979 - 989
  • [22] Pre-operative hyperfractionated radiotherapy and concurrent 5-FU/cisplatin for locally advanced esophageal cancer - The impact of 18-F-fluoro-deoxy-D-glucose (FDG) positron emission tomography staging
    Farmer, MR
    Edward, L
    Westcott, C
    Mishra, G
    Melin, S
    Ho, C
    Blackstock, AW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S416 - S417
  • [23] Pre-operative hyperfractionated radiotherapy and concurrent 5-FU/cisplatin for locally advanced esophageal cancer - the impact of 18-F-fluora-deoxy-D-glucose (FDG) positron emission tomography staging.
    Farmer, MR
    Levine, E
    Ho, C
    Mishra, G
    Melin, S
    Lovato, J
    Geisinger, K
    Oaks, T
    Clark, P
    Blackstock, AW
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 326S - 326S
  • [24] Phase II, multicenter, open-label, non-randomized study of neoadjuvant chemotherapy NALIRINOX (5-FU/LV + oxaliplatin plus nal-IRI) followed by chemoradiotherapy in patients with rectal cancer in a watch-and-wait program.
    Munoz, Cesar Gregorio
    Martinez, Maria Carmen Riesco
    Ugidos, Lisardo
    Garcia-Alfonso, Pilar
    Alvarez, Rafael
    Peinado, Paloma
    Garcia, Marcial
    Torres, Marisa
    Cubillo, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: Updated results of 3-year disease-free survival from a randomized phase II study (The ADORE).
    Hong, Yong Sang
    Nam, Byung-Ho
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Park, Joon Oh
    Park, Young Suk
    Kim, Sun Young
    Kim, Tae-You
    Kim, Jee Hyun
    Ahn, Joong Bae
    Jung, Kyung Hae
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
123